2.56
price down icon1.16%   -0.03
after-market Dopo l'orario di chiusura: 2.49 -0.07 -2.73%
loading

Psyence Biomedical Ltd Borsa (PBM) Ultime notizie

pulisher
Mar 04, 2026

How Psyence Biomedical Ltd. stock performs in interest rate cyclesWall Street Watch & High Yield Equity Trading Tips - mfd.ru

Mar 04, 2026
pulisher
Mar 03, 2026

Psyence Biomed announces export of GMP-manufactured natural psilocybin (NPX-5) to Australia for ongoing clinical trial phase IIb - marketscreener.com

Mar 03, 2026
pulisher
Mar 03, 2026

Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial - The Manila Times

Mar 03, 2026
pulisher
Mar 03, 2026

Natural psilocybin shipped to Australia for cancer palliative care trial - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

Psyence Biomedical Finalizes PsyLabs Share Swap, Settlement-Linked Loan and Board Changes - TipRanks

Mar 02, 2026
pulisher
Mar 02, 2026

Large share exchange boosts Psyence Labs’ stake in Psyence Biomedical (PBM) - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

VIX Spike: Will Psyence Biomedical Ltd Equity Warrant outperform tech stocks2025 Market Sentiment & Verified Entry Point Signals - baoquankhu1.vn

Mar 01, 2026
pulisher
Mar 01, 2026

Aug EndMonth: Can Psyence Biomedical Ltd Equity Warrant beat the S P 5002025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 28, 2026

Will Psyence Biomedical Ltd. Equity Warrant benefit from government policyGap Down & Accurate Technical Buy Alerts - mfd.ru

Feb 28, 2026
pulisher
Feb 27, 2026

PBM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

PBM Earnings History & Surprises | EPS & Revenue Results | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill

Feb 27, 2026
pulisher
Feb 25, 2026

PBM PE Ratio & Valuation, Is PBM Overvalued - Intellectia AI

Feb 25, 2026
pulisher
Feb 24, 2026

Movement Recap: Is Psyence Biomedical Ltd Equity Warrant undervalued by DCF analysisMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 23, 2026

Psyence Biomedical shares rise following equity investment agreement - MSN

Feb 23, 2026
pulisher
Feb 23, 2026

Psyence BioMed Announces Exercise Of Put Option By Psyence Labs; Stock Up - Nasdaq

Feb 23, 2026
pulisher
Feb 23, 2026

Psyence Biomedical stock gains on equity investment deal By Investing.com - Investing.com Canada

Feb 23, 2026
pulisher
Feb 21, 2026

Aug Rallies: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Trade Ideas & AI Forecast Swing Trade Picks - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 20, 2026

Is Psyence Biomedical Ltd.’s ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence Biomedical Shares Soar 70% Following Partner’s Ibogaine Extraction Breakthrough - MSN

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence BioMed Exercises Put Option to Invest in PsyLabs - Intellectia AI

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence Biomedical Cedes 49.98% Stake to PsyLabs in US$5 Million Share Swap - TipRanks

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence Biomedical Ltd. Invests in Psyence Labs Ltd. to Enhance Strategic Relationship and Supply Chain Capabilities - Quiver Quantitative

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment - The Spec

Feb 20, 2026
pulisher
Feb 20, 2026

Psyence Biomedical Shareholders Approve Board, Auditor and Share Consolidation Authority - The Globe and Mail

Feb 20, 2026
pulisher
Feb 20, 2026

PBM SEC FilingsPsyence Biomedical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 20, 2026
pulisher
Feb 20, 2026

Does Psyence Biomedical Ltd. stock have upside surprise potential2025 Buyback Activity & Reliable Entry Point Trade Alerts - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Weiner discloses 51,850-share, 5.07% stake in Psyence Biomedical (PBM) - Stock Titan

Feb 19, 2026
pulisher
Feb 18, 2026

Growth Review: Does Bitfarms Ltd align with a passive investing strategyTrade Performance Summary & Real-Time Stock Entry Alerts - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 18, 2026

Will Psyence Biomedical Ltd. outperform its industry peersMarket Sentiment Report & Precise Trade Entry Recommendations - mfd.ru

Feb 18, 2026
pulisher
Feb 17, 2026

Psyence BioMed Announces Results of Annual and Special Meeting of Shareholders - Bitget

Feb 17, 2026
pulisher
Feb 17, 2026

Psyence Biomedical Ltd. Announces Shareholder Meeting Results, Directors Elected and Share Consolidation Authority Granted - Quiver Quantitative

Feb 17, 2026
pulisher
Feb 17, 2026

Psilocybin developer’s investors back plan to combine shares up to 250-for-1 - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Sectors Review: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500Weekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Feb 16, 2026
pulisher
Feb 14, 2026

Why Psyence Biomedical Ltd. Equity Warrant stock could outperform in 2025Oil Prices & AI Forecast for Swing Trade Picks - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Psyence Biomedical Ratifies Put Option Deal With PsyLabs to Secure Psychedelic Supply - The Globe and Mail

Feb 14, 2026
pulisher
Feb 13, 2026

PsyLabs Secures Strategic Put Option Deal With Psyence BioMed to Scale Psychedelic API Manufacturing - TipRanks

Feb 13, 2026
pulisher
Feb 13, 2026

Psyence BioMed Enters Put Option Agreement with PsyLabs - Intellectia AI

Feb 13, 2026
pulisher
Feb 13, 2026

Psyence Biomedical Ltd. Enters Put Option Agreement with PsyLabs to Strengthen Strategic Partnership in Psychedelic Manufacturing - Quiver Quantitative

Feb 13, 2026
pulisher
Feb 13, 2026

Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway - The Spec

Feb 13, 2026
pulisher
Feb 13, 2026

Psyence BioMed Approves Put Option Agreement With PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway - 富途牛牛

Feb 13, 2026
pulisher
Feb 12, 2026

Psyence Biomedical Settles Shareholder Dispute With KAOS Capital - TipRanks

Feb 12, 2026
pulisher
Feb 12, 2026

Activity Recap: How does Psyence Biomedical Ltd Equity Warrant perform in inflationary periodsIPO Watch & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 11, 2026

PSYENCE BIOMEDICAL LTD TO PAY KAOS CAPITAL $1.5 MILLION IN SETTLEMENT - Intellectia AI

Feb 11, 2026
pulisher
Feb 11, 2026

Psyence Biomedical announces settlement of shareholder litigation - TipRanks

Feb 11, 2026
pulisher
Feb 11, 2026

Psyence Biomed announces settlement of shareholder litigation - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Psyence Biomedical Ltd. Reaches Settlement Agreement with KAOS Capital Ltd. to Resolve Shareholder Claims - Quiver Quantitative

Feb 11, 2026
pulisher
Feb 11, 2026

Psyence BioMed Announces Settlement of Shareholder Litigation - ChartMill

Feb 11, 2026
pulisher
Feb 11, 2026

Published on: 2026-02-11 15:38:29 - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Is Psyence Biomedical Ltd. stock forming a triangle patternWeekly Trend Recap & Risk Managed Investment Signals - mfd.ru

Feb 10, 2026
pulisher
Feb 10, 2026

Revenue Check: Can Psyence Biomedical Ltd Equity Warrant beat the S P 500July 2025 Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn

Feb 10, 2026
pulisher
Feb 09, 2026

Aug Final Week: Is Xenon Pharmaceuticals Inc a play on infrastructure spendingBond Market & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 08, 2026

Aug Sentiment: Whats the beta of Psyence Biomedical Ltd stock2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Feb 08, 2026
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Capitalizzazione:     |  Volume (24 ore):